TuHURA BIOSCIENCES, INC./NV Increase (Decrease) in Notes Payable, Current
TuHURA BIOSCIENCES, INC./NV (HURA) reported Increase (Decrease) in Notes Payable, Current of $2.38 thousand for the 30-month period ending 2011-12-31, per its 10-Q filed 2012-02-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInNotesPayableCurrent · last filed 2012-02-07
- 2011-12-31: Increase (Decrease) in Notes Payable, Current 6 month $2.38K; Increase (Decrease) in Notes Payable, Current 30 month $2.38K.
- 2010-12-31: Increase (Decrease) in Notes Payable, Current 6 month $0.00.
| Period end | Increase (Decrease) in Notes Payable, Current 6 month | Increase (Decrease) in Notes Payable, Current 30 month |
|---|---|---|
| 2011-12-31 | $2.38K 10-Q · filed 2012-02-07 | $2.38K 10-Q · filed 2012-02-07 |
| 2010-12-31 | $0.00 10-Q · filed 2012-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |